December 11, 2018
Effective for group health insurance policies issued or renewed on or after Jan. 1, 2019, SB 242 requires coverage for long-term antibiotic therapy for an insured with Lyme disease. The therapy must be determined to be medically necessary and ordered by a licensed physician after the physician has made a thorough evaluation of the insured’s symptoms, diagnostic test results or response to treatment.
SB 242 »